3-187236125-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_139125.4(MASP1):​c.1746G>A​(p.Pro582Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00712 in 1,613,866 control chromosomes in the GnomAD database, including 66 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0051 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0073 ( 65 hom. )

Consequence

MASP1
NM_139125.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.20

Publications

6 publications found
Variant links:
Genes affected
MASP1 (HGNC:6901): (MBL associated serine protease 1) This gene encodes a serine protease that functions as a component of the lectin pathway of complement activation. The complement pathway plays an essential role in the innate and adaptive immune response. The encoded protein is synthesized as a zymogen and is activated when it complexes with the pathogen recognition molecules of lectin pathway, the mannose-binding lectin and the ficolins. This protein is not directly involved in complement activation but may play a role as an amplifier of complement activation by cleaving complement C2 or by activating another complement serine protease, MASP-2. The encoded protein is also able to cleave fibrinogen and factor XIII and may may be involved in coagulation. A splice variant of this gene which lacks the serine protease domain functions as an inhibitor of the complement pathway. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
MASP1 Gene-Disease associations (from GenCC):
  • 3MC syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • 3MC syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 3-187236125-C-T is Benign according to our data. Variant chr3-187236125-C-T is described in ClinVar as Benign. ClinVar VariationId is 285006.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.2 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00513 (781/152306) while in subpopulation SAS AF = 0.0197 (95/4824). AF 95% confidence interval is 0.0165. There are 1 homozygotes in GnomAd4. There are 403 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 65 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MASP1NM_139125.4 linkc.1746G>A p.Pro582Pro synonymous_variant Exon 11 of 11 ENST00000296280.11 NP_624302.1 P48740-2
MASP1NM_001879.6 linkc.1303+5356G>A intron_variant Intron 10 of 15 ENST00000337774.10 NP_001870.3 P48740-1
MASP1NR_033519.2 linkn.1619G>A non_coding_transcript_exon_variant Exon 10 of 10

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MASP1ENST00000296280.11 linkc.1746G>A p.Pro582Pro synonymous_variant Exon 11 of 11 1 NM_139125.4 ENSP00000296280.7 P48740-2
MASP1ENST00000337774.10 linkc.1303+5356G>A intron_variant Intron 10 of 15 1 NM_001879.6 ENSP00000336792.5 P48740-1

Frequencies

GnomAD3 genomes
AF:
0.00514
AC:
782
AN:
152188
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00183
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00662
Gnomad EAS
AF:
0.0110
Gnomad SAS
AF:
0.0199
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00658
Gnomad OTH
AF:
0.00764
GnomAD2 exomes
AF:
0.00673
AC:
1683
AN:
250114
AF XY:
0.00728
show subpopulations
Gnomad AFR exome
AF:
0.00165
Gnomad AMR exome
AF:
0.00249
Gnomad ASJ exome
AF:
0.00417
Gnomad EAS exome
AF:
0.00871
Gnomad FIN exome
AF:
0.000934
Gnomad NFE exome
AF:
0.00579
Gnomad OTH exome
AF:
0.00789
GnomAD4 exome
AF:
0.00733
AC:
10716
AN:
1461560
Hom.:
65
Cov.:
80
AF XY:
0.00761
AC XY:
5532
AN XY:
727116
show subpopulations
African (AFR)
AF:
0.00179
AC:
60
AN:
33478
American (AMR)
AF:
0.00313
AC:
140
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00471
AC:
123
AN:
26136
East Asian (EAS)
AF:
0.0171
AC:
680
AN:
39700
South Asian (SAS)
AF:
0.0202
AC:
1745
AN:
86256
European-Finnish (FIN)
AF:
0.00111
AC:
59
AN:
53108
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5768
European-Non Finnish (NFE)
AF:
0.00675
AC:
7507
AN:
1111998
Other (OTH)
AF:
0.00652
AC:
394
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
803
1606
2410
3213
4016
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00513
AC:
781
AN:
152306
Hom.:
1
Cov.:
33
AF XY:
0.00541
AC XY:
403
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00183
AC:
76
AN:
41556
American (AMR)
AF:
0.00392
AC:
60
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00662
AC:
23
AN:
3472
East Asian (EAS)
AF:
0.0110
AC:
57
AN:
5182
South Asian (SAS)
AF:
0.0197
AC:
95
AN:
4824
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00659
AC:
448
AN:
68032
Other (OTH)
AF:
0.00756
AC:
16
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
37
74
112
149
186
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00570
Hom.:
1
Bravo
AF:
0.00524
Asia WGS
AF:
0.0160
AC:
57
AN:
3478
EpiCase
AF:
0.00551
EpiControl
AF:
0.00528

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 02, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 25, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

3MC syndrome 1 Benign:1
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.79
DANN
Benign
0.28
PhyloP100
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3821805; hg19: chr3-186953913; COSMIC: COSV99961983; API